Carcinoma, Non-Small-Cell Lung: all 6,641 studies
Page 9 of 67. Open to participants first (1,665), then studies with results posted, then the rest; newest registration first within each.
- Chemotherapy Plus Immunotherapy Combined With SBRT as Neoadjuvant Therapy for Patients With Resectable NSCLCRecruitingNCT06718309Phase 2
- The CCANED-CIPHER Study: Early Cancer Detection and Treatment Response Monitoring Using AI-Based Platelet and Immune Cell Transcriptomic ProfilingRecruitingNCT06717295
- Feasibility Study of Personalized Ultra-fractionated Stereotactic Ablative Radiotherapy (PULSAR) for Cancers of the Central LungRecruitingNCT06712745Early Phase 1
- Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer (ROSETTA Lung-02)RecruitingNCT06712316Phase 2/3
- Effect of G-CSF on MDSC and Cancer Stem-cells Interactions in Non-small Cell Lung Cancers (CIRCUIT)Not yet recruitingNCT06711770Not applicable
- Afatinib Combined With Chemotherapy as Conversion Therapy in Unresectable EGFR Sensitive Mutation-positive Stage III NSCLCRecruitingNCT06709859Phase 2
- Minimal Residual Disease Guiding Adjuvant Therapy in Stage I NSCLCNot yet recruitingNCT06709274Not applicable
- Study of BEBT-109 in Subjects With EGFR Exon 20 Insertion Mutations Non-Small Cell Lung CancerRecruitingNCT06706713Phase 2
- Efficacy and Safety of Sacituzumab Tirumotecan (SKB264) in Combination With Toripalimab in Patients With Initially Unresectable Stage III NSCLCNot yet recruitingNCT06706219Phase 2
- A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 MutationsRecruitingNCT06706076Phase 1/2
- Cross-sectorial Rehabilitation of Patients with Lung CancerRecruitingNCT06705465Not applicable
- Study of Tislelizumab and Platinum-based Chemotherapy Combination With H1 Receptor Antagonist（Diphenhydramine）in Advanced and Metastatic Non-Small Cell Lung CancerNot yet recruitingNCT06704620Phase 3
- Cadonilimab Combined With Stereotactic Radiotherapy as Second-line Treatment for Brain MetastasesRecruitingNCT06702826Phase 2
- Multi-omics Study of Early-stage Lung Cancer With Distinct PhenotypesRecruitingNCT06699979
- Cerebrospinal Fluid Immune Microenvironment Mechanism in Anaplastic Lymphoma Kinase Positive Lung Cancer PatientsNot yet recruitingNCT06697990Phase 2
- A Phase 2 Study of Zanidatamab in Patients With HER2-expressing TumorsRecruitingNCT06695845Phase 2
- Real-world Observational Study of Targeted Therapy in Patients With Advanced ROS1-positive NSCLCNot yet recruitingNCT06694129
- An Adjuvant Study to Evaluate SMS001 (Paclitaxel) in Non-Small Cell Lung CancerRecruitingNCT06693336Phase 2
- A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)RecruitingNCT06692738Phase 3
- A Single-Arm, Phase Ⅰb Study of Golidocitinib Combined With Anti-PD-1 for the Treatment of Previously Treated NSCLCNot yet recruitingNCT06690671Phase 1/2
- Real-world Study of Local Therapy Changes During 1L Lorlatinib in Unresectable ALK+ NSCLCNot yet recruitingNCT06690541
- Evaluation of [18F]AlF-NOTA-PCP2 PET/CT for PD-L1 Detection in Malignant TumorsEnrolling by invitationNCT06690216Phase 1/2
- Incentive Spirometry to Improve Outcomes in Lung Cancer Patients Undergoing Concurrent Chemotherapy and Radiation TherapyRecruitingNCT06688422Not applicable
- A Study to Evaluate the Tolerability, Safety, and PK of AST-201 in Patients With GPC3-positive Advanced Solid TumorsRecruitingNCT06687941Phase 1
- Sleeve Lobectomy for Lung Cancer in Minimally Invasive Surgical TechniquesRecruitingNCT06687408
- Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung CancerRecruitingNCT06686771Phase 3
- Artificial Intelligence-based Model for the Prediction of Occult Lymph Node Metastasis and Improvement of Clinical Decision-making in Non-small Cell Lung CancerRecruitingNCT06684418
- Utidelone Injection Combined with Bevacizumab Injection for Non-small Cell Lung Cancer Patients with Brain MetastasesNot yet recruitingNCT06683703Phase 2
- Lorlatinib as Neoadjuvant Treatment in Stage IB-IIIB ALK-rearranged Non-Small Cell Lung CancerNot yet recruitingNCT06682884Phase 2
- A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 ExpressionRecruitingNCT06682793Phase 1/2
- Furmonertinib 160mg as First-line Treatment in Locally Advanced or Metastatic NSCLC With EGFR Classical MutationsRecruitingNCT06674343Phase 3
- A Study of TY-9591 With Chemotherapy as 1st Line Treatment in Patients With Mutated Epidermal Growth Factor Receptor NSCLCNot yet recruitingNCT06672068Phase 2
- Evaluating a Fasting-mimicking Diet in Combination With Immunotherapy in Patients With Non-small Cell Lung CancerRecruitingNCT06671613Not applicable
- FIH Trial of VERT-002 in Patients With Locally Advanced or Metastatic Solid Tumors With MET AlterationsRecruitingNCT06669117Phase 1/2
- A Phase 2 Clinical Study of Combination Therapy With ABSK043 and FirmonertinibRecruitingNCT06668103Phase 2
- A Study of JNJ-90301900 in Combination With Chemoradiation Followed by Consolidation Immunotherapy for Non-Small Cell Lung Cancer (NSCLC)RecruitingNCT06667908Phase 2
- Efficacy Analysis of Neoadjuvant Treatment in Lung Cancer Using Low-dose Nivolumab Combined With ChemotherapyRecruitingNCT06667154Phase 2
- A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)RecruitingNCT06667076Phase 2
- Intrathecal Injection Pemetrexed And Bevacizumab in Patients With Leptomeningeal Metastases in NSCLCRecruitingNCT06663306Phase 1
- Perioperative Tislelizumab for Resectable II-IIIB(N2) KRAS-mutated Nonsquamous Non-small Cell Lung CancerRecruitingNCT06659042Phase 2
- Adjuvant Chemotherapy +/- Cemiplimab and Sequential Hypofractionated Radiotherapy in Unfit or Elderly Patients With Stage III Lung CancerRecruitingNCT06656598Phase 2
- High-dose Furmonertinib or Combined With Chemotherapy in EGFR-mutant Advanced NSCLC After Disease Progression on Third-generation EGFR-TKIRecruitingNCT06652048Phase 2
- Radiolabelled Nectin-4 Targeted LMW Probe PET/CT in Patients With Lung LesionsRecruitingNCT06648317
- SEgmentectomy Versus Lobectomy in T1C Non-Small Cell Lung Cancer (SELTIC)Not yet recruitingNCT06646770Not applicable
- PROspective Master-protocol for Evaluation of Systemic THErapeutics in Elderly With Thoracic MalignanciesRecruitingNCT06646471Phase 4
- Post-Market Surveillance Study of ALK-Positive Advanced NSCLC Participants Treated With IruplinalkibNot yet recruitingNCT06644495
- Vebreltinib for Neoadjuvant in MET-altered Stage IIIA-IIIB (N2) Non-small Cell Lung Cancer (NSCLC)Not yet recruitingNCT06644313Phase 2
- A Study on the Safety and Efficacy of BST08 in Treating Advanced Non-Small Cell Lung CancerNot yet recruitingNCT06643910Not applicable
- A Phase I Study of CFT8919 in Patients With Advanced NSCLCRecruitingNCT06641609Phase 1
- [177Lu]Lu-AKIR001 First-in-human StudyRecruitingNCT06639191Early Phase 1
- 3-Dimensional Virtual Reality Modelling With Intravascular Indocyanine Green Fluorescence Mapping for Targeted Pulmonary Segmental Resection TrialNot yet recruitingNCT06638125Phase 1/2
- Selective Lymph Node Resection for Invasive Non-small Cell Lung Cancer With the CTR of 0.5-1 and the Diameter of ≤ 2 cmRecruitingNCT06634979Not applicable
- Third-generation EGFR-TKI Plus Anlotinib as Maintenance for NSCLC With Small Cell Transformation After EGFR-TKI ResistanceNot yet recruitingNCT06634667Phase 2
- Study of Antitumor Immune Response After cCRT and IO Treatment in Non-resectable III Stage NSCLC PatientsRecruitingNCT06634199
- Pneumonitis Prevention Protocol Using Pentoxifylline and α-tocopherol In Stage III Non-Small Cell Lung Cancer Patients Undergoing ChemoradiationRecruitingNCT06634056Phase 2
- A Phase 2 Clinical Study of ABSK061 and ABSK043RecruitingNCT06632262Phase 2
- Locally Advanced NSCLC Treated With Radiochemotherapy: Phase 2 Study on the Value of a Stereotactic BoostRecruitingNCT06627738Phase 2
- Analysis of RATS, VATS and Open Lung Resections After Neoadjuvant Chemo-immunotherapy in Patients Performed in Five Referred CentersRecruitingNCT06626243
- Open-Label Study of BBO-10203 in Subjects With Advanced Solid TumorsRecruitingNCT06625775Phase 1
- Preoperative Radioimmunotherapy Versus Chemoimmunotherapy in NSCLCRecruitingNCT06623656Phase 2
- The Application Value of 68Ga-grazytracer PET in Immunotherapy for Stage III Non-small-cell Lung CancerRecruitingNCT06623487
- A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)RecruitingNCT06623422Phase 3
- Pulse Radiotherapy to Overcome Metastatic Immune System Evasion in Lung CancerRecruitingNCT06622174Phase 1
- Phase Ib Trial of HS-20117 in Combination With Other Drugs in Advanced Solid TumorsRecruitingNCT06621563Phase 1
- Efficacy of PD-1 Inhibitor Combination Therapy in Non-small Cell Lung Cancer Patients Who Have Not Achieved Major Pathologic Response After Neoadjuvant Immunotherapy: a Multicenter, Phase II Clinical TrialNot yet recruitingNCT06620822Phase 2
- Local Injection and Systemic Therapy in the Treatment of NSCLC.Not yet recruitingNCT06618391Phase 2
- A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid TumorsRecruitingNCT06618287Phase 1/2
- A Study of AK104 in Subjects With Unresectable Locally Advanced NSCLCRecruitingNCT06617416Phase 3
- A Phase 1/2, Open-label, Multicenter, FIH Study to Evaluate Safety, Tolerability, PK and Anti-tumor Activity of YH42946RecruitingNCT06616766Phase 1/2
- Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)RecruitingNCT06616584Phase 2/3
- Neoajuvant Tislelizumab Combined with Chemotherapy for Initially Unresectable Stage IIIA/N2 Non-small Cell Lung CancerNot yet recruitingNCT06614231Phase 2
- A Study of GNC-077 in Patients With Locally Advanced or Metastatic Non-small-cell Lung Cancer and Other Solid TumorsRecruitingNCT06612840Phase 1
- Neoadjuvant With Tα1 Plus Immuno-chemotherapy for Resectable NSCLCNot yet recruitingNCT06607926Not applicable
- Pan-tumor MRD StudyRecruitingNCT06605404
- AI-guided Prognostication and Cranial Radiotherapy Optimization in EGFR-TKI-treated Non-small Cell Lung Cancer Patients With Baseline Brain MetastasesRecruitingNCT06604689
- Using CICS-1 and SPM-011 and ［18F］FBPA Commissioned by CICS and Sumitomo Heavy Industries and STELLA PHARMAEnrolling by invitationNCT06603987Phase 1/2
- Reinforced and Non-Reinforced Staple Lines in Fissureless LobectomyNot yet recruitingNCT06602661Phase 1
- Immuno-effect of Tα1 for Stage I NSCLCRecruitingNCT06598839Not applicable
- Safety and Efficacy of BA1302 in Patients With Advanced Solid TumorsRecruitingNCT06596915Phase 1
- A Phase Ib Study of HS-10370 in Addition to Other Anti-cancer Therapies in Participants with KRAS G12C Mutation Advanced Solid TumorsNot yet recruitingNCT06594874Phase 1
- Induction Therapy With Serplulimab Combined With Chemotherapy for Unresectable Stage III Non-small Cell Lung CancerNot yet recruitingNCT06591910
- PH009-1 in Patients With EGFR Mutation Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC)Not yet recruitingNCT06590194Phase 1/2
- A Study of SHR-A2102 in Combination With Adebrelimab and SHR-8068 in Subjects With Locally Advanced or Metastatic Non-Small Cell Lung CancerRecruitingNCT06589778Phase 1/2
- The Patient-Reported Outcomes in ALK Positive Advanced NSCLC in ChinaNot yet recruitingNCT06586801
- Clinical Trial of TQB2928 in Combination With a Third-Generation Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor (TKI) in Patients With Advanced Non-Small Cell Lung CancersNot yet recruitingNCT06585059Phase 1
- Elimination of PTV Margins Based on MRI-guided Adaptive Stereotactic Radiotherapy for Non-small Cell Lung Cancer With Brain MetastasisRecruitingNCT06582940Phase 2
- Cryoablation with or Without Serplulimab in Treating Patients with Stage I-IIA Non-small Cell Lung CancerNot yet recruitingNCT06580665Not applicable
- Vebreltinib Plus PLB1004 as the First-line Therapy for Patients With EGFRm+/MET+ Locally Advanced or Metastatic NSCLC.RecruitingNCT06574347Phase 2
- Evaluation of Clinical Performance and IVD Test of LifeOS Digital PCR Liquid Biopsy Kits for EGFR T790M MutationRecruitingNCT06573073
- A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)RecruitingNCT06568939Phase 2
- Cancer-related Fatigue During Maintenance Immunotherapy for Non-small Cell Lung Cancer (NSCLC): a Qualitative StudyRecruitingNCT06567704
- Study of FIH of STX-241 in Locally Advanced or Metastatic NSCLC Resistant to EGFR TKIsRecruitingNCT06567015Phase 1/2
- Honokiol in Early-Stage Resectable Non-Small Cell Lung CancerRecruitingNCT06566443Phase 1
- A Phase III Study Comparing Taletrectinib With Standard Therapy in ROS1 Positive Locally Advanced or Metastatic Non-small Cell Lung Cancer PatientsRecruitingNCT06564324Phase 3
- Neoadjuvant Umbrella Trial for Patients With Unresectable Stage III NSCLC Harboring Rare Mutations.RecruitingNCT06563999Phase 2
- Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal CancersRecruitingNCT06562192Phase 1
- A Study of LY4050784 in Participants With Advanced or Metastatic Solid TumorsRecruitingNCT06561685Phase 1
- A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%RecruitingNCT06561386Phase 3
- CSF CTC-Capture-Guided EGFR-TKI and Bevacizumab Combination Therapy in EGFR-Mutant Advanced NSCLCNot yet recruitingNCT06557096Early Phase 1
- Olanzapine Impact on First-line Immunotherapy for Advanced EGFR-negative NSCLCRecruitingNCT06554613Phase 2